MD Biosciences Offers IL-23-Induced Psoriasis-Like Preclinical Model for Skin Inflammation MD Biosciences focuses on rapid and cost effective models of psoriasis involving the IL-23/Th17 axis in order to provide companies alternatives to complex and cost prohibitive xenotransplantation models for screening. With the earlier launch of the IMQ model and now the IL-23 psoriasis model, MD Biosciences offers a range of rapid models for dermal conditions such as dermatitis and psoriasis ...
Aug. 8, 2013 - PRWeb